0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Safe Insulin Syringes Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21M14287
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Safe Insulin Syringes Market Research Report 2023
BUY CHAPTERS

Global Safe Insulin Syringes Market Research Report 2025

Code: QYRE-Auto-21M14287
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Safe Insulin Syringes Market

The global market for Safe Insulin Syringes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Safe Insulin Syringes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Safe Insulin Syringes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Safe Insulin Syringes include Accutome, B. Braun, Biocon Ltd, Ypsomed AG, BD, Abbott Laboratories, Novo Nordisk, F. Hoffmann-La Roche, AlShifa, Terumo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Safe Insulin Syringes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safe Insulin Syringes.
The Safe Insulin Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Safe Insulin Syringes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safe Insulin Syringes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Safe Insulin Syringes Market Report

Report Metric Details
Report Name Safe Insulin Syringes Market
Segment by Type
  • Reusable
  • Single Use
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Accutome, B. Braun, Biocon Ltd, Ypsomed AG, BD, Abbott Laboratories, Novo Nordisk, F. Hoffmann-La Roche, AlShifa, Terumo, Hunan Pingan Medical Devices, Zhejiang Kindly Medical Devices, Medtronic Plc, Sanofi, Wockhardt Ltd, HTL-Strefa, Animas Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Safe Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Safe Insulin Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Safe Insulin Syringes Market report?

Ans: The main players in the Safe Insulin Syringes Market are Accutome, B. Braun, Biocon Ltd, Ypsomed AG, BD, Abbott Laboratories, Novo Nordisk, F. Hoffmann-La Roche, AlShifa, Terumo, Hunan Pingan Medical Devices, Zhejiang Kindly Medical Devices, Medtronic Plc, Sanofi, Wockhardt Ltd, HTL-Strefa, Animas Corporation

What are the Application segmentation covered in the Safe Insulin Syringes Market report?

Ans: The Applications covered in the Safe Insulin Syringes Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Safe Insulin Syringes Market report?

Ans: The Types covered in the Safe Insulin Syringes Market report are Reusable, Single Use

1 Safe Insulin Syringes Market Overview
1.1 Product Definition
1.2 Safe Insulin Syringes by Type
1.2.1 Global Safe Insulin Syringes Market Value Comparison by Type (2024 VS 2031)
1.2.2 Reusable
1.2.3 Single Use
1.3 Safe Insulin Syringes by Application
1.3.1 Global Safe Insulin Syringes Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Safe Insulin Syringes Market Size Estimates and Forecasts
1.4.1 Global Safe Insulin Syringes Revenue 2020-2031
1.4.2 Global Safe Insulin Syringes Sales 2020-2031
1.4.3 Global Safe Insulin Syringes Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Safe Insulin Syringes Market Competition by Manufacturers
2.1 Global Safe Insulin Syringes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Safe Insulin Syringes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Safe Insulin Syringes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Safe Insulin Syringes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Safe Insulin Syringes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Safe Insulin Syringes, Product Type & Application
2.7 Global Key Manufacturers of Safe Insulin Syringes, Date of Enter into This Industry
2.8 Global Safe Insulin Syringes Market Competitive Situation and Trends
2.8.1 Global Safe Insulin Syringes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Safe Insulin Syringes Players Market Share by Revenue
2.8.3 Global Safe Insulin Syringes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Safe Insulin Syringes Market Scenario by Region
3.1 Global Safe Insulin Syringes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Safe Insulin Syringes Sales by Region: 2020-2031
3.2.1 Global Safe Insulin Syringes Sales by Region: 2020-2025
3.2.2 Global Safe Insulin Syringes Sales by Region: 2026-2031
3.3 Global Safe Insulin Syringes Revenue by Region: 2020-2031
3.3.1 Global Safe Insulin Syringes Revenue by Region: 2020-2025
3.3.2 Global Safe Insulin Syringes Revenue by Region: 2026-2031
3.4 North America Safe Insulin Syringes Market Facts & Figures by Country
3.4.1 North America Safe Insulin Syringes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Safe Insulin Syringes Sales by Country (2020-2031)
3.4.3 North America Safe Insulin Syringes Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Safe Insulin Syringes Market Facts & Figures by Country
3.5.1 Europe Safe Insulin Syringes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Safe Insulin Syringes Sales by Country (2020-2031)
3.5.3 Europe Safe Insulin Syringes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Safe Insulin Syringes Market Facts & Figures by Region
3.6.1 Asia Pacific Safe Insulin Syringes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Safe Insulin Syringes Sales by Region (2020-2031)
3.6.3 Asia Pacific Safe Insulin Syringes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Safe Insulin Syringes Market Facts & Figures by Country
3.7.1 Latin America Safe Insulin Syringes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Safe Insulin Syringes Sales by Country (2020-2031)
3.7.3 Latin America Safe Insulin Syringes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Safe Insulin Syringes Market Facts & Figures by Country
3.8.1 Middle East and Africa Safe Insulin Syringes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Safe Insulin Syringes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Safe Insulin Syringes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Safe Insulin Syringes Sales by Type (2020-2031)
4.1.1 Global Safe Insulin Syringes Sales by Type (2020-2025)
4.1.2 Global Safe Insulin Syringes Sales by Type (2026-2031)
4.1.3 Global Safe Insulin Syringes Sales Market Share by Type (2020-2031)
4.2 Global Safe Insulin Syringes Revenue by Type (2020-2031)
4.2.1 Global Safe Insulin Syringes Revenue by Type (2020-2025)
4.2.2 Global Safe Insulin Syringes Revenue by Type (2026-2031)
4.2.3 Global Safe Insulin Syringes Revenue Market Share by Type (2020-2031)
4.3 Global Safe Insulin Syringes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Safe Insulin Syringes Sales by Application (2020-2031)
5.1.1 Global Safe Insulin Syringes Sales by Application (2020-2025)
5.1.2 Global Safe Insulin Syringes Sales by Application (2026-2031)
5.1.3 Global Safe Insulin Syringes Sales Market Share by Application (2020-2031)
5.2 Global Safe Insulin Syringes Revenue by Application (2020-2031)
5.2.1 Global Safe Insulin Syringes Revenue by Application (2020-2025)
5.2.2 Global Safe Insulin Syringes Revenue by Application (2026-2031)
5.2.3 Global Safe Insulin Syringes Revenue Market Share by Application (2020-2031)
5.3 Global Safe Insulin Syringes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Accutome
6.1.1 Accutome Company Information
6.1.2 Accutome Description and Business Overview
6.1.3 Accutome Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Accutome Safe Insulin Syringes Product Portfolio
6.1.5 Accutome Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Company Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 B. Braun Safe Insulin Syringes Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 Biocon Ltd
6.3.1 Biocon Ltd Company Information
6.3.2 Biocon Ltd Description and Business Overview
6.3.3 Biocon Ltd Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biocon Ltd Safe Insulin Syringes Product Portfolio
6.3.5 Biocon Ltd Recent Developments/Updates
6.4 Ypsomed AG
6.4.1 Ypsomed AG Company Information
6.4.2 Ypsomed AG Description and Business Overview
6.4.3 Ypsomed AG Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ypsomed AG Safe Insulin Syringes Product Portfolio
6.4.5 Ypsomed AG Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BD Safe Insulin Syringes Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories Company Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbott Laboratories Safe Insulin Syringes Product Portfolio
6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novo Nordisk Safe Insulin Syringes Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Company Information
6.8.2 F. Hoffmann-La Roche Description and Business Overview
6.8.3 F. Hoffmann-La Roche Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 F. Hoffmann-La Roche Safe Insulin Syringes Product Portfolio
6.8.5 F. Hoffmann-La Roche Recent Developments/Updates
6.9 AlShifa
6.9.1 AlShifa Company Information
6.9.2 AlShifa Description and Business Overview
6.9.3 AlShifa Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AlShifa Safe Insulin Syringes Product Portfolio
6.9.5 AlShifa Recent Developments/Updates
6.10 Terumo
6.10.1 Terumo Company Information
6.10.2 Terumo Description and Business Overview
6.10.3 Terumo Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Terumo Safe Insulin Syringes Product Portfolio
6.10.5 Terumo Recent Developments/Updates
6.11 Hunan Pingan Medical Devices
6.11.1 Hunan Pingan Medical Devices Company Information
6.11.2 Hunan Pingan Medical Devices Description and Business Overview
6.11.3 Hunan Pingan Medical Devices Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hunan Pingan Medical Devices Safe Insulin Syringes Product Portfolio
6.11.5 Hunan Pingan Medical Devices Recent Developments/Updates
6.12 Zhejiang Kindly Medical Devices
6.12.1 Zhejiang Kindly Medical Devices Company Information
6.12.2 Zhejiang Kindly Medical Devices Description and Business Overview
6.12.3 Zhejiang Kindly Medical Devices Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Kindly Medical Devices Safe Insulin Syringes Product Portfolio
6.12.5 Zhejiang Kindly Medical Devices Recent Developments/Updates
6.13 Medtronic Plc
6.13.1 Medtronic Plc Company Information
6.13.2 Medtronic Plc Description and Business Overview
6.13.3 Medtronic Plc Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Medtronic Plc Safe Insulin Syringes Product Portfolio
6.13.5 Medtronic Plc Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sanofi Safe Insulin Syringes Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Wockhardt Ltd
6.15.1 Wockhardt Ltd Company Information
6.15.2 Wockhardt Ltd Description and Business Overview
6.15.3 Wockhardt Ltd Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Wockhardt Ltd Safe Insulin Syringes Product Portfolio
6.15.5 Wockhardt Ltd Recent Developments/Updates
6.16 HTL-Strefa
6.16.1 HTL-Strefa Company Information
6.16.2 HTL-Strefa Description and Business Overview
6.16.3 HTL-Strefa Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.16.4 HTL-Strefa Safe Insulin Syringes Product Portfolio
6.16.5 HTL-Strefa Recent Developments/Updates
6.17 Animas Corporation
6.17.1 Animas Corporation Company Information
6.17.2 Animas Corporation Description and Business Overview
6.17.3 Animas Corporation Safe Insulin Syringes Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Animas Corporation Safe Insulin Syringes Product Portfolio
6.17.5 Animas Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Safe Insulin Syringes Industry Chain Analysis
7.2 Safe Insulin Syringes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Safe Insulin Syringes Production Mode & Process Analysis
7.4 Safe Insulin Syringes Sales and Marketing
7.4.1 Safe Insulin Syringes Sales Channels
7.4.2 Safe Insulin Syringes Distributors
7.5 Safe Insulin Syringes Customer Analysis
8 Safe Insulin Syringes Market Dynamics
8.1 Safe Insulin Syringes Industry Trends
8.2 Safe Insulin Syringes Market Drivers
8.3 Safe Insulin Syringes Market Challenges
8.4 Safe Insulin Syringes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Safe Insulin Syringes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Safe Insulin Syringes Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Safe Insulin Syringes Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Safe Insulin Syringes Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Safe Insulin Syringes Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Safe Insulin Syringes Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Safe Insulin Syringes Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Safe Insulin Syringes Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Safe Insulin Syringes, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Safe Insulin Syringes, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Safe Insulin Syringes, Product Type & Application
 Table 12. Global Key Manufacturers of Safe Insulin Syringes, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Safe Insulin Syringes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safe Insulin Syringes as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Safe Insulin Syringes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Safe Insulin Syringes Sales by Region (2020-2025) & (K Units)
 Table 18. Global Safe Insulin Syringes Sales Market Share by Region (2020-2025)
 Table 19. Global Safe Insulin Syringes Sales by Region (2026-2031) & (K Units)
 Table 20. Global Safe Insulin Syringes Sales Market Share by Region (2026-2031)
 Table 21. Global Safe Insulin Syringes Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Safe Insulin Syringes Revenue Market Share by Region (2020-2025)
 Table 23. Global Safe Insulin Syringes Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Safe Insulin Syringes Revenue Market Share by Region (2026-2031)
 Table 25. North America Safe Insulin Syringes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Safe Insulin Syringes Sales by Country (2020-2025) & (K Units)
 Table 27. North America Safe Insulin Syringes Sales by Country (2026-2031) & (K Units)
 Table 28. North America Safe Insulin Syringes Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Safe Insulin Syringes Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Safe Insulin Syringes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Safe Insulin Syringes Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Safe Insulin Syringes Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Safe Insulin Syringes Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Safe Insulin Syringes Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Safe Insulin Syringes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Safe Insulin Syringes Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Safe Insulin Syringes Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Safe Insulin Syringes Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Safe Insulin Syringes Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Safe Insulin Syringes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Safe Insulin Syringes Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Safe Insulin Syringes Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Safe Insulin Syringes Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Safe Insulin Syringes Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Safe Insulin Syringes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Safe Insulin Syringes Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Safe Insulin Syringes Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Safe Insulin Syringes Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Safe Insulin Syringes Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Safe Insulin Syringes Sales (K Units) by Type (2020-2025)
 Table 51. Global Safe Insulin Syringes Sales (K Units) by Type (2026-2031)
 Table 52. Global Safe Insulin Syringes Sales Market Share by Type (2020-2025)
 Table 53. Global Safe Insulin Syringes Sales Market Share by Type (2026-2031)
 Table 54. Global Safe Insulin Syringes Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Safe Insulin Syringes Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Safe Insulin Syringes Revenue Market Share by Type (2020-2025)
 Table 57. Global Safe Insulin Syringes Revenue Market Share by Type (2026-2031)
 Table 58. Global Safe Insulin Syringes Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Safe Insulin Syringes Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Safe Insulin Syringes Sales (K Units) by Application (2020-2025)
 Table 61. Global Safe Insulin Syringes Sales (K Units) by Application (2026-2031)
 Table 62. Global Safe Insulin Syringes Sales Market Share by Application (2020-2025)
 Table 63. Global Safe Insulin Syringes Sales Market Share by Application (2026-2031)
 Table 64. Global Safe Insulin Syringes Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Safe Insulin Syringes Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Safe Insulin Syringes Revenue Market Share by Application (2020-2025)
 Table 67. Global Safe Insulin Syringes Revenue Market Share by Application (2026-2031)
 Table 68. Global Safe Insulin Syringes Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Safe Insulin Syringes Price (US$/Unit) by Application (2026-2031)
 Table 70. Accutome Company Information
 Table 71. Accutome Description and Business Overview
 Table 72. Accutome Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Accutome Safe Insulin Syringes Product
 Table 74. Accutome Recent Developments/Updates
 Table 75. B. Braun Company Information
 Table 76. B. Braun Description and Business Overview
 Table 77. B. Braun Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. B. Braun Safe Insulin Syringes Product
 Table 79. B. Braun Recent Developments/Updates
 Table 80. Biocon Ltd Company Information
 Table 81. Biocon Ltd Description and Business Overview
 Table 82. Biocon Ltd Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Biocon Ltd Safe Insulin Syringes Product
 Table 84. Biocon Ltd Recent Developments/Updates
 Table 85. Ypsomed AG Company Information
 Table 86. Ypsomed AG Description and Business Overview
 Table 87. Ypsomed AG Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ypsomed AG Safe Insulin Syringes Product
 Table 89. Ypsomed AG Recent Developments/Updates
 Table 90. BD Company Information
 Table 91. BD Description and Business Overview
 Table 92. BD Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BD Safe Insulin Syringes Product
 Table 94. BD Recent Developments/Updates
 Table 95. Abbott Laboratories Company Information
 Table 96. Abbott Laboratories Description and Business Overview
 Table 97. Abbott Laboratories Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Abbott Laboratories Safe Insulin Syringes Product
 Table 99. Abbott Laboratories Recent Developments/Updates
 Table 100. Novo Nordisk Company Information
 Table 101. Novo Nordisk Description and Business Overview
 Table 102. Novo Nordisk Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Novo Nordisk Safe Insulin Syringes Product
 Table 104. Novo Nordisk Recent Developments/Updates
 Table 105. F. Hoffmann-La Roche Company Information
 Table 106. F. Hoffmann-La Roche Description and Business Overview
 Table 107. F. Hoffmann-La Roche Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. F. Hoffmann-La Roche Safe Insulin Syringes Product
 Table 109. F. Hoffmann-La Roche Recent Developments/Updates
 Table 110. AlShifa Company Information
 Table 111. AlShifa Description and Business Overview
 Table 112. AlShifa Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AlShifa Safe Insulin Syringes Product
 Table 114. AlShifa Recent Developments/Updates
 Table 115. Terumo Company Information
 Table 116. Terumo Description and Business Overview
 Table 117. Terumo Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Terumo Safe Insulin Syringes Product
 Table 119. Terumo Recent Developments/Updates
 Table 120. Hunan Pingan Medical Devices Company Information
 Table 121. Hunan Pingan Medical Devices Description and Business Overview
 Table 122. Hunan Pingan Medical Devices Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hunan Pingan Medical Devices Safe Insulin Syringes Product
 Table 124. Hunan Pingan Medical Devices Recent Developments/Updates
 Table 125. Zhejiang Kindly Medical Devices Company Information
 Table 126. Zhejiang Kindly Medical Devices Description and Business Overview
 Table 127. Zhejiang Kindly Medical Devices Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Kindly Medical Devices Safe Insulin Syringes Product
 Table 129. Zhejiang Kindly Medical Devices Recent Developments/Updates
 Table 130. Medtronic Plc Company Information
 Table 131. Medtronic Plc Description and Business Overview
 Table 132. Medtronic Plc Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Medtronic Plc Safe Insulin Syringes Product
 Table 134. Medtronic Plc Recent Developments/Updates
 Table 135. Sanofi Company Information
 Table 136. Sanofi Description and Business Overview
 Table 137. Sanofi Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sanofi Safe Insulin Syringes Product
 Table 139. Sanofi Recent Developments/Updates
 Table 140. Wockhardt Ltd Company Information
 Table 141. Wockhardt Ltd Description and Business Overview
 Table 142. Wockhardt Ltd Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Wockhardt Ltd Safe Insulin Syringes Product
 Table 144. Wockhardt Ltd Recent Developments/Updates
 Table 145. HTL-Strefa Company Information
 Table 146. HTL-Strefa Description and Business Overview
 Table 147. HTL-Strefa Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. HTL-Strefa Safe Insulin Syringes Product
 Table 149. HTL-Strefa Recent Developments/Updates
 Table 150. Animas Corporation Company Information
 Table 151. Animas Corporation Description and Business Overview
 Table 152. Animas Corporation Safe Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Animas Corporation Safe Insulin Syringes Product
 Table 154. Animas Corporation Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Safe Insulin Syringes Distributors List
 Table 158. Safe Insulin Syringes Customers List
 Table 159. Safe Insulin Syringes Market Trends
 Table 160. Safe Insulin Syringes Market Drivers
 Table 161. Safe Insulin Syringes Market Challenges
 Table 162. Safe Insulin Syringes Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Safe Insulin Syringes
 Figure 2. Global Safe Insulin Syringes Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Safe Insulin Syringes Market Share by Type: 2024 & 2031
 Figure 4. Reusable Product Picture
 Figure 5. Single Use Product Picture
 Figure 6. Global Safe Insulin Syringes Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Safe Insulin Syringes Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Safe Insulin Syringes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Safe Insulin Syringes Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Safe Insulin Syringes Sales (2020-2031) & (K Units)
 Figure 14. Global Safe Insulin Syringes Average Price (US$/Unit) & (2020-2031)
 Figure 15. Safe Insulin Syringes Report Years Considered
 Figure 16. Safe Insulin Syringes Sales Share by Manufacturers in 2024
 Figure 17. Global Safe Insulin Syringes Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Safe Insulin Syringes Players: Market Share by Revenue in Safe Insulin Syringes in 2024
 Figure 19. Safe Insulin Syringes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Safe Insulin Syringes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Safe Insulin Syringes Sales Market Share by Country (2020-2031)
 Figure 22. North America Safe Insulin Syringes Revenue Market Share by Country (2020-2031)
 Figure 23. United States Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Safe Insulin Syringes Sales Market Share by Country (2020-2031)
 Figure 26. Europe Safe Insulin Syringes Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Safe Insulin Syringes Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Safe Insulin Syringes Revenue Market Share by Region (2020-2031)
 Figure 34. China Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Safe Insulin Syringes Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Safe Insulin Syringes Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Safe Insulin Syringes Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Safe Insulin Syringes Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Safe Insulin Syringes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Safe Insulin Syringes by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Safe Insulin Syringes by Type (2020-2031)
 Figure 53. Global Safe Insulin Syringes Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Safe Insulin Syringes by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Safe Insulin Syringes by Application (2020-2031)
 Figure 56. Global Safe Insulin Syringes Price (US$/Unit) by Application (2020-2031)
 Figure 57. Safe Insulin Syringes Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc